9 reports

  • 9.2 Growing Incidence of Cancer Patients in South Korea
  • South Korea- Number of Patient Diagnosed With Cancer (Thousand), 2009 - 2016
  • Cancer
  • South Korea
  • Forecast
  • Market Size
  • Varian Medical Systems, Inc.
  • 7.2 Growing Incidence of Cancer Patients
  • SOUTH KOREA - NUMBER OF PATIENT DIAGNOSED WITH CANCER (NUMBER), 2007 - 2016
  • Cancer
  • Specialty Hospital
  • South Korea
  • Forecast
  • Market Size
  • Enteral Stenting for Other Indications*
  • 5.1.4 Japan

Stomach cancer and colorectal cancer are the two cancers with the highest incidence rates in Japan.

  • Cancer
  • New Zealand
  • South Korea
  • Boston Scientific Corporation
  • Taewoong Medical
  • Mar 07, 2016: Spectrum Pharmaceuticals Initiates Phase 2 Breast Cancer Trial for Poziotinib, a Novel Pan-HER Inhibitor
  • 06/02/2016: Boehringer Ingelheim launches ambitious ELUXA trial program to broadly investigate promising lung cancer compound olmutinib
  • Cancer
  • Healthcare
  • Pharmaceutical
  • South Korea
  • Hanmi Science Co., Ltd.
  • Green Cross Cell Corp - Opportunities
  • SWOT Analysis

Senior citizens already contribute a great deal to the sales of drugs for most of the age related cancers such as breast cancer, prostate cancer, lung cancer, colorectal cancer, non-Hodgkin' s lymphoma, melanoma, and brain cancer.

  • Cancer
  • Pharmaceutical
  • South Korea
  • Company Financials
  • GlobalData's company
  • Tyrosine Protein Kinase CSK (C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 2.7.10.2) - Drug Profiles
  • Pipeline by Athenex Inc, H2 2017
  • Cancer
  • Therapy
  • South Korea
  • Product Initiative
  • Pfizer Inc.
  • EARLYTECT BREAST CANCER
  • EARLYTECT COLON CANCER - PRODUCT DESCRIPTION
  • Cancer
  • Colorectal Cancer
  • Molecular Diagnostic
  • South Korea
  • GlobalData's company
  • EQUITY OFFERING
  • DKR Oasis Management Acquires Minority Stake In Innocell

The company offers Immuncell-LC, an anti-cancer immune therapeutic that is derived from lymphocytes of cancer patient.

  • Cancer
  • South Korea
  • Company
  • Corporate Finance
  • GlobalData's company
  • BUKWANG PHARMA ENTERS INTO CO-DEVELOPMENT AGREEMENT WITH LSK BIOPARTNER AND WEST COAST CLINICAL
  • PARTNERSHIPS

The company is developing proprietary drug candidate apatinib, a selective VEGFR-## inhibitor for the treatment of solid tumor cancers such as metastatic gastric carcinoma, colorectal cancer, hepatocellular carcinoma, metastatic breast cancer and non-small cell lung

  • Cancer
  • Healthcare
  • Pharmaceutical
  • South Korea
  • Pharm Co Ltd